RHOH and neoplasm: The univariate analysis for survival with TTF-1 expression and several clinicopathologic factors indicated that sex (male), TNM stage (IIIB or IV), smoking (60 pack-years or more), specimen type (biopsy), and tumor location (peripheral) correlated significantly with prognosis (Table 3).